Novartis AG (NOVN.SW) SIX
123.20
+0.3(+0.24%)
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
123.20
+0.3(+0.24%)
Currency In CHF
| Market Cap | 268.06B |
| Enterprise Value | 293.64B |
| P/E Ratio | 21.09 |
| PEG Ratio | -10.32 |
| Price/Sales Ratio | 5.24 |
| Price/Book Ratio | 6.41 |
| Enterprise/Revenue | 5.69 |
| Enterprise/EBITDA | 14.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.25 |
| Operating Margin | 0.31 |
| Return On Assets | 0.12 |
| Return On Equity | 0.33 |
| Revenue | 57.13B |
| Revenue/Share | 29.41 |
| Gross Profit | 42.86B |
| EBITDA | 23.96B |
| Net Income | 14.65B |
| Diluted EPS | 7.49 |
| Total Cash | 11.58B |
| Total Cash/Share | 6.05 |
| Total Debt | 37.01B |
| Total Debt/Equity | 0.8 |
| Current Ratio | 1.12 |
| Book Value Per Share | 24.32 |
| 52-Week Change | 26.62 |
| 52-Week High | 131 |
| 52-Week Low | 81.1 |
| Moving Average 50 Days | 121.89 |
| Moving Average 200 Days | 107.42 |
| Average Volume | 3.38M |
| Shares Outstanding | 1.91B |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 3.01 |
| Trailing Annual Dividend Yield | 1.95 |
| Payout Ratio | 0.54 |
| Last Split Factor | 6:5 |
| Last Split Date | October 04, 2023 |